IBO vs RF
Impact BioMedical, Inc. (IBO) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
RF does not have a complete income-statement cache yet.
IBO currently screens at market cap $7.6M. RF currently screens at market cap $0.
Not investment advice. Open the IBO and RF stock pages for the full models.
Not investment advice.